Japan· JP-6343434D6020
エプタコグアルファ（活性型）（遺伝子組換え）
A medicinal product containing エプタコグアルファ（活性型）（遺伝子組換え）, registered in Japan by ノボ ノルディスク ファーマ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エプタコグアルファ（活性型）（遺伝子組換え）
- Manufacturer
- ノボ ノルディスク ファーマ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
エプタコグアルファ（活性型）（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCevenfacta 1mg (45,000units) powder and solvent for solution for injection vialsLFB Biopharmaceuticals Ltd
- IrelandCEVENFACTA 1 mg (45 KIU) powder and solvent for solution for injectionLaboratoire francais du Fractionnement et des Biotechnolgies
- BelgiumCevenfacta 1 mgLaboratoire français du Fractionnement et des Biotechnologies
- CzechiaCEVENFACTALaboratoire Français du Fractionnement et des Biotechnologies, Puteaux
- SwedenCEVENFACTA 1 mg Pulver och vätska till injektionsvätska, lösningLaboratoire français du Fractionnement et des Biotechnologies
- FinlandNovosevenOrifarm Oy
- SpainNOVOSEVEN 1 mg (50 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- SwitzerlandNovoSeven 1 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungNovo Nordisk Pharma AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cevenfacta, Novoseven
- Liechtenstein · Cevenfacta
- Norway · Cevenfacta, Novoseven
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4f67580b-f522-4bae-8a12-ad180ae74e7c GET /v1/drugs/4f67580b-f522-4bae-8a12-ad180ae74e7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｍｇ１ｍＬ１瓶（溶解液付）",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "6343434D6020",
"category": "注射薬",
"price_yen": 82739,
"generic_name": "エプタコグアルファ（活性型）（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "6343",
"transitional_expiry": null
}See everything about エプタコグアルファ（活性型）（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.